BMS are hoping to seal approval from Japanese health authorities for their new all-oral treatment regimen for hepatitis C.
Read more on the story here:
BMS are hoping to seal approval from Japanese health authorities for their new all-oral treatment regimen for hepatitis C.
Read more on the story here: